Paychex Inc: Form 10-Q for the period ended Aug 31, 2024
Filed with the SEC on Oct 1, 2024 and accepted by EDGAR at Oct 1, 2024, 16:21 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2024-08-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2024-06-01 to 2024-08-31 | $1.28bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2024-06-01 to 2024-08-31 | $380.0m | us-gaap:CostOfRevenue |
| Selling, general and administrative | 3 months2024-06-01 to 2024-08-31 | $391.8m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2024-06-01 to 2024-08-31 | $546.7m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2024-06-01 to 2024-08-31 | $9.6m | us-gaap:InterestExpense |
| Income tax | 3 months2024-06-01 to 2024-08-31 | $129.7m | us-gaap:IncomeTaxExpenseBenefit |
| Diluted EPS | 3 months2024-06-01 to 2024-08-31 | $1.18 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2024-06-01 to 2024-08-31 | $1.19 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2024-06-01 to 2024-08-31 | 361,900,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months2024-06-01 to 2024-08-31 | $546.1m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months2024-06-01 to 2024-08-31 | $35.6m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 3 months2024-06-01 to 2024-08-31 | $353.4m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 3 months2024-06-01 to 2024-08-31 | $104.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2024-08-31 | $1.46bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2024-08-31 | $7.36bn | us-gaap:AssetsCurrent |
| Total assets | At period end2024-08-31 | $10.49bn | us-gaap:Assets |
| Current liabilities | At period end2024-08-31 | $5.34bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2024-08-31 | $6.64bn | us-gaap:Liabilities |
| Long-term debt | At period end2024-08-31 | $798.7m | us-gaap:LongTermDebtNoncurrent |
| Short-term borrowings | At period end2024-08-31 | $18.9m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2024-08-31 | $3.85bn | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2024-08-31 | 359,898,021 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0000950170-24-110834. Last ingested by Listed: Oct 27, 2026, 16:32 ET. Listed shows no prices and gives no investment advice.